Processa Pharmaceuticals, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Processa Pharmaceuticals, Inc. (PCSA) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $90.00 thousand as of 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2014-05-14
- 2014-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $90.00K.
- 2013-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $16.00K.
- 2013-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $16.00K.
- 2013-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $5.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2014-03-31 | $90.00K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $16.00K 10-K · filed 2014-03-27 |
| 2013-09-30 | $16.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $5.00K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |